Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Bridget Brosnihan
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Disorders
Physiology
Sign-in to see full Profile
Network (preview)
72
Ferrario, Carlos
29
Chappell, Mark
14
Diz, Debra
14
Neves, Liomar
13
Averill, David
12
Gallagher, Patricia
10
Herrington, David
9
Santos, Robson
8
Merrill, David
7
Anton, Lauren
7
Tallant, Ann
6
Ganten, Detlev
6
Khosla, Mahesh
5
Joyner, JaNae
5
Li, P
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Bridget Brosnihan (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Anton Lauren; Merrill David C; Neves Liomar A A; Diz Debra I; Corthorn Jenny; Valdes Gloria; Stovall Kathryn; Gallagher Patricia E; Moorefield Cheryl; Gruver Courtney; Brosnihan K Bridget
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy.
Endocrinology 2009;150(9):4316-25.
-
2009: Lindsey Sarah Hoffmann; Cohen Jonathan A; Brosnihan K Bridget; Gallagher Patricia E; Chappell Mark C
Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.
Endocrinology 2009;150(8):3753-8.
-
2009: Sugulle Meryam; Dechend Ralf; Herse Florian; Weedon-Fekjaer M Susanne; Johnsen Guro M; Brosnihan K Bridget; Anton Lauren; Luft Friedrich C; Wollert Kai C; Kempf Tibor; Staff Anne Cathrine
Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus.
Hypertension 2009;54(1):106-12.
-
2009: Valdes Gloria; Kaufmann Peter; Corthorn Jenny; Erices Rafaela; Brosnihan K Bridget; Joyner-Grantham Janae
Vasodilator factors in the systemic and local adaptations to pregnancy.
Reproductive biology and endocrinology : RB&E 2009;7():79.
-
2008: Anton Lauren; Brosnihan K Bridget
Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.
Therapeutic advances in cardiovascular disease 2008;2(5):349-62.
-
2008: Pendergrass Karl D; Pirro Nancy T; Westwood Brian M; Ferrario Carlos M; Brosnihan K Bridget; Chappell Mark C
Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.
American journal of physiology. Heart and circulatory physiology 2008;295(1):H10-20.
-
2008: Brosnihan K Bridget; Li Ping; Figueroa Jorge P; Ganten Detlev; Ferrario Carlos M
Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats.
American journal of physiology. Heart and circulatory physiology 2008;294(5):H1995-2001.
-
2008: Brosnihan K Bridget; Hodgin Jeffrey B; Smithies Oliver; Maeda Nobuyo; Gallagher Patricia
Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice.
Experimental physiology 2008;93(5):658-64.
-
2008: Anton Lauren; Merrill David C; Neves Liomar A A; Stovall Kathryn; Gallagher Patricia E; Diz Debra I; Moorefield Cheryl; Gruver Courtney; Ferrario Carlos M; Brosnihan K Bridget
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.
Hypertension 2008;51(4):1066-72.
-
2008: Joyner J; Neves L A A; Stovall K; Ferrario C M; Brosnihan K B
Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;294(3):R1073-80.
-
2008: Lakoski Susan G; Liu Yongmei; Brosnihan K Bridget; Herrington David M
Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.
Atherosclerosis 2008;197(1):443-7.
-
2008: Schindler C; Ferrario C M; Jatzke C; Ahner K; Brosnihan K B; Bramlage P; Maywald U; Oertel R; Boecking W; Kirch W
Characterization of vascular reactivity in dorsal hand veins after oral rosiglitazone treatment in healthy subjects.
International journal of clinical pharmacology and therapeutics 2008;46(1):30-9.
-
2008: Neves Liomar A A; Stovall Kathryn; Joyner JaNae; Valdés Gloria; Gallagher Patricia E; Ferrario Carlos M; Merrill David C; Brosnihan K Bridget
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;294(1):R151-61.
-
2007: Anton Lauren; Merrill David C; Neves Liomar A A; Brosnihan K Bridget
Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor.
Endocrine 2007;32(2):212-8.
-
2007: Pignone Alberto; Rosso Angela Del; Brosnihan K Bridget; Perfetto Federico; Livi Riccardo; Fiori Ginevra; Guiducci Serena; Cinelli Marina; Rogai Veronica; Tempestini Alessio; Bartoli Francesca; Generini Sergio; Ferrario Carlos M; Cerinic Marco Matucci
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.
Annals of the rheumatic diseases 2007;66(10):1305-10.
-
2007: Gironacci Mariela M; Brosnihan K Bridget; Ferrario Carlos M; Gorzalczany Susana; Verrilli María A Lopez; Pascual Mariano; Taira Carlos; Peña Clara
Increased hypothalamic angiotensin-(1-7) levels in rats with aortic coarctation-induced hypertension.
Peptides 2007;28(8):1580-5.
-
2007: Grigore Daniela; Ojeda Norma B; Robertson Elliot B; Dawson Antoinette S; Huffman Contrina A; Bourassa Erick A; Speth Robert C; Brosnihan K Bridget; Alexander Barbara T
Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(2):R804-11.
-
2007: Joyner J; Neves L A A; Granger J P; Alexander B T; Merrill D C; Chappell M C; Ferrario C M; Davis W P; Brosnihan K B
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(1):R169-77.
-
2007: Lakoski Susan G; Li Liwu; Langefeld Carl D; Liu Yongmei; Howard Timothy D; Brosnihan K Bridget; Xu Jianfeng; Bowden Donald W; Herrington David M
The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study.
Experimental and molecular pathology 2007;82(3):280-3.
-
2007: Schindler Christoph; Brosnihan K Bridget; Ferrario Carlos M; Bramlage Peter; Maywald Ulf; Koch Rainer; Oertel Reinhard; Kirch Wilhelm
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
Journal of clinical pharmacology 2007;47(1):112-20.
-
2006: Lange Leslie A; Burdon Kathryn; Langefeld Carl D; Liu Yongmei; Beck Stephanie R; Rich Stephen S; Freedman Barry I; Brosnihan K Bridget; Herrington David M; Wagenknecht Lynne E; Bowden Donald W
Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study.
Annals of human genetics 2006;70(Pt 6):717-25.
-
2006: Neves L A A; Chappell M C; Ferrario C M; Gallagher P E; Ganten D; Brosnihan K B
Effect of estrogen on neprilysin expression in uterus and kidney of Sprague-Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats.
Peptides 2006;27(11):2912-8.
-
2006: Jessup Jewell A; Gallagher Patricia E; Averill David B; Brosnihan K Bridget; Tallant E Ann; Chappell Mark C; Ferrario Carlos M
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
American journal of physiology. Heart and circulatory physiology 2006;291(5):H2166-72.
-
2006: Valdés G; Neves L A A; Anton L; Corthorn J; Chacón C; Germain A M; Merrill D C; Ferrario C M; Sarao R; Penninger J; Brosnihan K B
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies.
Placenta 2006;27(2-3):200-7.
-
2006: Smith Ronald D; Yokoyama Hiroshi; Averill David B; Cooke Lori; Brosnihan K Bridget; Schiffrin Ernesto L; Ferrario Carlos M
The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(5):335-42.
-
2005: Bowden Donald W; Lange Leslie A; Langefeld Carl D; Brosnihan K Bridget; Freedman Barry I; Carr J Jeffrey; Wagenknecht Lynne E; Herrington David M
The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS).
American heart journal 2005;150(5):1032-8.
-
2005: Ferrario Carlos M; Jessup Jewell; Gallagher Patricia E; Averill David B; Brosnihan K Bridget; Ann Tallant E; Smith Ronald D; Chappell Mark C
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Kidney international 2005;68(5):2189-96.
-
2005: Brosnihan K Bridget; Neves Liomar A A; Chappell Mark C
Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?
Hypertension 2005;46(5):1097-9.
-
2005: Yokoyama Hiroshi; Averill David B; Brosnihan K Bridget; Smith Ronald D; Schiffrin Ernesto L; Ferrario Carlos M
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
American journal of hypertension 2005;18(7):922-9.
-
2005: Ferrario Carlos M; Jessup Jewell; Chappell Mark C; Averill David B; Brosnihan K Bridget; Tallant E Ann; Diz Debra I; Gallagher Patricia E
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Circulation 2005;111(20):2605-10.
-
2004: Brosnihan K B; Neves L A A; Anton L; Joyner J; Valdes G; Merrill D C
Enhanced expression of Ang-(1-7) during pregnancy.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2004;37(8):1255-62.
-
2004: Neves Liomar A A; Averill David B; Ferrario Carlos M; Aschner Judy L; Brosnihan K Bridget
Vascular responses to Angiotensin-(1-7) during the estrous cycle.
Endocrine 2004;24(2):161-5.
-
2004: Ishiyama Yuichiro; Gallagher Patricia E; Averill David B; Tallant E Ann; Brosnihan K Bridget; Ferrario Carlos M
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Hypertension 2004;43(5):970-6.
-
2004: Modrall J Gregory; Sadjadi Javid; Brosnihan K Bridget; Gallagher Patricia E; Yu Chun-hua; Kramer Gerald L; Bernstein Kenneth E; Chappell Mark C
Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides.
Hypertension 2004;43(4):849-53.
-
2004: Seely Ellen W; Brosnihan K Bridget; Jeunemaitre Xavier; Okamura Kyoko; Williams Gordon H; Hollenberg Norman K; Herrington David M
Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.
Clinical endocrinology 2004;60(3):315-21.
-
2004: Sane David C; Anton Lauren; Brosnihan K Bridget
Angiogenic growth factors and hypertension.
Angiogenesis 2004;7(3):193-201.
-
2003: Chappell Mark C; Gallagher Patricia E; Averill David B; Ferrario Carlos M; Brosnihan K Bridget
Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.
Hypertension 2003;42(4):781-6.
-
2003: Brosnihan K Bridget; Neves Liomar A A; Joyner JaNae; Averill David B; Chappell Mark C; Sarao Renu; Penninger Josef; Ferrario Carlos M
Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy.
Hypertension 2003;42(4):749-53.
-
2003: Neves Liomar A A; Williams Aleck F; Averill David B; Ferrario Carlos M; Walkup Michael P; Brosnihan K Bridget
Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7).
Endocrinology 2003;144(8):3338-43.
-
2003: Neves Liomar A A; Averill David B; Ferrario Carlos M; Chappell Mark C; Aschner Judy L; Walkup Michael P; Brosnihan K Bridget
Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries.
Peptides 2003;24(3):455-62.
-
2003: Abdelhamed Abdelhamed I; Reis Steven E; Sane David C; Brosnihan K Bridget; Preli Robert B; Herrington David M
No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia.
American heart journal 2003;145(3):E15.
-
2003: Nakamura Shigefumi; Averill David B; Chappell Mark C; Diz Debra I; Brosnihan K Bridget; Ferrario Carlos M
Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR.
American journal of physiology. Regulatory, integrative and comparative physiology 2003;284(1):R164-73.
-
2002: Ferrario Carlos M; Averill David B; Brosnihan K Bridget; Chappell Mark C; Iskandar Samy S; Dean Richard H; Diz Debra I
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.
Kidney international 2002;62(4):1349-57.
-
2002: Merrill David C; Karoly Michael; Chen Kai; Ferrario Carlos M; Brosnihan K Bridget
Angiotensin-(1-7) in normal and preeclamptic pregnancy.
Endocrine 2002;18(3):239-45.
-
2002: Herrington David M; Howard Timothy D; Brosnihan K Bridget; McDonnell Donald P; Li Xiaolin; Hawkins Gregory A; Reboussin David M; Xu Jianfeng; Zheng Siqun L; Meyers Deborah A; Bleecker Eugene R
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
Circulation 2002;105(16):1879-82.
-
2002: Herrington David M; Howard Timothy D; Hawkins Gregory A; Reboussin David M; Xu Jianfeng; Zheng Siqun L; Brosnihan K Bridget; Meyers Deborah A; Bleecker Eugene R
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
The New England journal of medicine 2002;346(13):967-74.
-
2002: Wei Chih-Chang; Ferrario Carlos M; Brosnihan K Bridget; Farrell Diane M; Bradley Wayne E; Jaffa Ayad A; Dell'Italia Louis J
Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo.
The Journal of pharmacology and experimental therapeutics 2002;300(1):324-9.
-
2001: Valdés G; Germain A M; Corthorn J; Berrios C; Foradori A C; Ferrario C M; Brosnihan K B
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.
Endocrine 2001;16(2):117-22.
-
2001: Herrington D M; Brosnihan K B; Pusser B E; Seely E W; Ridker P M; Rifai N; MacLean D B
Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women.
The Journal of clinical endocrinology and metabolism 2001;86(9):4216-22.
-
2001: Fukuhara M; Neves L A; Li P; Diz D I; Ferrario C M; Brosnihan K B
The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
Journal of hypertension 2001;19(3 Pt 2):561-6.
-
2000: Levy P J; Yunis C; Owen J; Brosnihan K B; Smith R; Ferrario C M
Inhibition of platelet aggregability by losartan in essential hypertension.
The American journal of cardiology 2000;86(11):1188-92.
-
2000: Herrington D M; Reboussin D M; Brosnihan K B; Sharp P C; Shumaker S A; Snyder T E; Furberg C D; Kowalchuk G J; Stuckey T D; Rogers W J; Givens D H; Waters D
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
The New England journal of medicine 2000;343(8):522-9.
-
2000: Herrington D M; Pusser B E; Riley W A; Thuren T Y; Brosnihan K B; Brinton E A; MacLean D B
Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(6):1606-12.
-
2000: Li P; Fukuhara M; Diz D I; Ferrario C M; Brosnihan K B
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
The Journal of pharmacology and experimental therapeutics 2000;292(1):238-46.
-
1999: Brosnihan K B; Senanayake P S; Li P; Ferrario C M
Bi-directional actions of estrogen on the renin-angiotensin system.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1999;32(4):373-81.
-
1999: Yamada K; Iyer S N; Chappell M C; Brosnihan K B; Fukuhara M; Ferrario C M
Differential response of angiotensin peptides in the urine of hypertensive animals.
Regulatory peptides 1999;80(1-2):57-66.
-
1999: Gallagher P E; Li P; Lenhart J R; Chappell M C; Brosnihan K B
Estrogen regulation of angiotensin-converting enzyme mRNA.
Hypertension 1999;33(1 Pt 2):323-8.
-
1998: Brosnihan K B
Effect of the angiotensin-(1-7) peptide on nitric oxide release.
The American journal of cardiology 1998;82(10A):17S-19S.
-
1998: Li P; Ferrario C M; Brosnihan K B
Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1998;32(2):198-205.
-
1998: Iyer S N; Chappell M C; Brosnihan K B; Ferrario C M
Role of AT1 and AT2 receptors in the plasma clearance of angiotensin II.
Journal of cardiovascular pharmacology 1998;31(3):464-9.
-
1998: Ferrario C M; Martell N; Yunis C; Flack J M; Chappell M C; Brosnihan K B; Dean R H; Fernandez A; Novikov S V; Pinillas C; Luque M
Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects.
American journal of hypertension 1998;11(2):137-46.
-
1998: Senanayake P S; Smeby R R; Martins A S; Moriguchi A; Kumagai H; Ganten D; Brosnihan K B
Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats.
Peptides 1998;19(10):1685-94.
-
1998: Brosnihan K B; Li P; Tallant E A; Ferrario C M
Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Biological research 1998;31(3):227-34.
-
1997: Ferrario C M; Chappell M C; Tallant E A; Brosnihan K B; Diz D I
Counterregulatory actions of angiotensin-(1-7).
Hypertension 1997;30(3 Pt 2):535-41.
-
1997: Brosnihan K B; Weddle D; Anthony M S; Heise C; Li P; Ferrario C M
Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys.
Journal of hypertension 1997;15(7):719-26.
-
1997: Li P; Ferrario C M; Ganten D; Brosnihan K B
Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release.
American journal of hypertension 1997;10(6):662-70.
-
1997: Li P; Ferrario C M; Brosnihan K B
Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
The Journal of pharmacology and experimental therapeutics 1997;281(3):1065-70.
-
1997: Li P; Chappell M C; Ferrario C M; Brosnihan K B
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Hypertension 1997;29(1 Pt 2):394-400.
-
1996: Milsted A; Nishimura M; Brosnihan K B; Ferrario C M
Differential regulation of angiotensinogen transcripts after renin infusion.
Hypertension 1996;28(4):678-81.
-
1996: Chappell M C; Brosnihan K B; Ferrario C M
Angiotensin peptide research overlooked.
Clinical chemistry 1996;42(9):1500-1.
-
1996: Luque M; Martin P; Martell N; Fernandez C; Brosnihan K B; Ferrario C M
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.
Journal of hypertension 1996;14(6):799-805.
-
1996: Brosnihan K B; Li P; Ferrario C M
Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.
Hypertension 1996;27(3 Pt 2):523-8.
-
1995: Kawabe H; Lopes O U; Brosnihan K B; Saruta T; Ferrario C M
Angiotensin II pressor activity depends on medial and lateral anterior hypothalamic pathways.
Angiology 1995;46(8):641-8.
-
1994: Moriguchi A; Ferrario C M; Brosnihan K B; Ganten D; Morris M
Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene.
The American journal of physiology 1994;267(3 Pt 2):R786-91.
-
1994: Brosnihan K B; Moriguchi A; Nakamoto H; Dean R H; Ganten D; Ferrario C M
Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene.
American journal of hypertension 1994;7(7 Pt 1):576-82.
-
1994: Moriguchi A; Brosnihan K B; Kumagai H; Ganten D; Ferrario C M
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
The American journal of physiology 1994;266(4 Pt 2):R1273-9.
-
1994: Senanayake P D; Moriguchi A; Kumagai H; Ganten D; Ferrario C M; Brosnihan K B
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.
Peptides 1994;15(5):919-26.
-
1993: Kohara K; Brosnihan K B; Ferrario C M
Angiotensin(1-7) in the spontaneously hypertensive rat.
Peptides 1993;14(5):883-91.
-
1993: Kawabe H; Lopes O U; Chernicky C L; Brosnihan K B; Saruta T; Ferrario C M
Effects of large and small transections of the preoptic-hypothalamic region on hydromineral regulation in rats.
Endocrine journal 1993;40(2):249-56.
-
1993: Welches W R; Brosnihan K B; Ferrario C M
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.
Life sciences 1993;52(18):1461-80.
-
1992: Chappell M C; Welches W R; Brosnihan K B; Ferrario C M
Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
Peptides 1992;13(5):943-6.
-
1992: Nishimura M; Milsted A; Block C H; Brosnihan K B; Ferrario C M
Tissue renin-angiotensin systems in renal hypertension.
Hypertension 1992;20(2):158-67.
-
1992: Yamamoto K; Chappell M C; Brosnihan K B; Ferrario C M
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats.
Hypertension 1992;19(6 Pt 2):692-6.
-
1992: Kohara K; Brosnihan K B; Ferrario C M; Milsted A
Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system.
The American journal of physiology 1992;262(5 Pt 1):E651-7.
-
1992: Collins G B; Brosnihan K B; Zuti R A; Messina M; Gupta M K
Neuroendocrine, fluid balance, and thirst responses to alcohol in alcoholics.
Alcoholism, clinical and experimental research 1992;16(2):228-33.
-
1992: Santos R A; Brosnihan K B; Jacobsen D W; DiCorleto P E; Ferrario C M
Production of angiotensin-(1-7) by human vascular endothelium.
Hypertension 1992;19(2 Suppl):II56-61.
-
1991: Ferrario C M; Brosnihan K B; Diz D I; Jaiswal N; Khosla M C; Milsted A; Tallant E A
Angiotensin-(1-7): a new hormone of the angiotensin system.
Hypertension 1991;18(5 Suppl):III126-33.
-
1991: Kohara K; Tabuchi Y; Senanayake P; Brosnihan K B; Ferrario C M
Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures.
Peptides 1991;12(5):1135-41.
-
1991: Chappell M C; Millsted A; Diz D I; Brosnihan K B; Ferrario C M
Evidence for an intrinsic angiotensin system in the canine pancreas.
Journal of hypertension 1991;9(8):751-9.
-
1991: Welches W R; Santos R A; Chappell M C; Brosnihan K B; Greene L J; Ferrario C M
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin.
Journal of hypertension 1991;9(7):631-8.
-
1991: Kohara K; Brosnihan K B; Chappell M C; Khosla M C; Ferrario C M
Angiotensin-(1-7). A member of circulating angiotensin peptides.
Hypertension 1991;17(2):131-8.
-
1990: Milsted A; Barna B P; Ransohoff R M; Brosnihan K B; Ferrario C M
Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5720-3.
-
1990: Chappell M C; Tallant E A; Brosnihan K B; Ferrario C M
Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line.
Peptides 1990;11(2):375-80.
-
1990: Ferrario C M; Barnes K L; Block C H; Brosnihan K B; Diz D I; Khosla M C; Santos R A
Pathways of angiotensin formation and function in the brain.
Hypertension 1990;15(2 Suppl):I13-9.
-
1990: Santos R A; Brum J M; Brosnihan K B; Ferrario C M
The renin-angiotensin system during acute myocardial ischemia in dogs.
Hypertension 1990;15(2 Suppl):I121-7.
-
1989: Chappell M C; Brosnihan K B; Diz D I; Ferrario C M
Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides.
The Journal of biological chemistry 1989;264(28):16518-23.
-
1989: Mullally D F; Brosnihan K B; Diz D I
Cardiovascular actions of intrahypothalamic injections of atrial natriuretic peptide.
Peptides 1989;10(5):1081-7.
-
1989: Campagnole-Santos M J; Diz D I; Santos R A; Khosla M C; Brosnihan K B; Ferrario C M
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats.
The American journal of physiology 1989;257(1 Pt 2):H324-9.
-
1988: Block C H; Santos R A; Brosnihan K B; Ferrario C M
Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain.
Peptides 1988;9(6):1395-401.
-
1988: Schiavone M T; Santos R A; Brosnihan K B; Khosla M C; Ferrario C M
Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):4095-8.
-
1988: Ferrario C M; Mohara O; Ueno Y; Brosnihan K B
Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog.
The American journal of the medical sciences 1988;295(4):352-9.
-
1988: Ueno Y; Mohara O; Brosnihan K B; Ferrario C M
Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension.
Hypertension 1988;11(2 Pt 2):I172-7.
-
1988: Brosnihan K B; Schiavone M T; Sprunger A E; Chappell M C; Rizzo M; Ferrario C M
In vivo release of angiotensin II from the rat hypothalamus.
Hypertension 1988;11(2 Pt 2):I158-62.
-
1988: Santos R A; Brosnihan K B; Chappell M C; Pesquero J; Chernicky C L; Greene L J; Ferrario C M
Converting enzyme activity and angiotensin metabolism in the dog brainstem.
Hypertension 1988;11(2 Pt 2):I153-7.
-
1988: Ferrario C M; Santos R A; Brosnihan K B; Block C H; Schiavone M T; Khosla M C; Greene L J
A hypothesis regarding the function of angiotensin peptides in the brain.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10 Suppl 1():107-21.
-
1987: Chappell M C; Brosnihan K B; Welches W R; Ferrario C M
Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog.
Peptides 1987;8(5):939-42.
-
1986: Schiavone M T; Brosnihan K B; Husain A; Ferrario C M
Basal and potassium-evoked release of angiotensin II from the rat hypothalamus.
Brain research 1986;397(1):193-6.
-
1983: Husain A; Bumpus F M; Smeby R R; Brosnihan K B; Khosla M C; Speth R C; Ferrario C M
Evidence for the existence of a family of biologically active angiotensin I-like peptides in the dog central nervous system.
Circulation research 1983;52(4):460-4.
-
1983: Suzuki H; Ferrario C M; Speth R C; Brosnihan K B; Smeby R R; de Silva P
Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs.
Hypertension 1983;5(2 Pt 2):I139-48.
-
1982: Brosnihan K B; Smeby R R; Ferrario C M
Effects of chronic sodium depletion on canine brain renin and cathepsin D activities.
Hypertension 1982;4(5):604-8.
Sign-in to see more